How Vet Medicines Get to Market: UK Licensing Explained

Understanding how veterinary medicines get to market is crucial for any vet who wants to prescribe confidently, legally, and with a clear view of the evidence. Veterinary Prescriber’s CPD module “How veterinary medicines get to market” explains the UK marketing authorisation process, what companies must submit to the regulator, and how the Summary of Product Characteristics (SPC) sets out the legal conditions of use for each licensed product. It also shows why Public Assessment Reports can be valuable when you want more detail than the SPC alone provides.

What the module covers

The module takes you through the essentials of veterinary medicines regulation in Great Britain and Northern Ireland, including:

• the post-Brexit licensing landscape,

• different types of marketing authorisation, and

• scientific assessment of quality, safety, and efficacy

• strengths and weaknesses of the licensing system.

It is especially useful for vets who need to compare new products with existing therapies and understand the limits of what regulatory approval can tell you in day-to-day practice.

A key strength of the module is that it goes beyond the basics of licensing. It explains how pharmacovigilance continues after approval, why real-world safety monitoring matters, and where the regulatory process can leave gaps in knowledge about comparative effectiveness. That makes it particularly relevant for vets looking for evidence-based prescribing support rather than promotional claims.

If you want CPD that helps you make sense of veterinary medicines regulation, licensing, SPCs, and Public Assessment Reports, Veterinary Prescriber is a strong resource to keep in your toolkit. It is designed to help vets stay current with new medicines, changing product information, and the practical realities of prescribing in practice.